Abstract
Bisphosphonates are indicated for treatment of osteolytic diseases, aiming to control bone resorption. These drugs show high affinity to mineral tissues and are released during traumatic or inflammatory events, leading to cytotoxic and cytopatic effects. For this reason, the installation of oral osseointegrated implants is still controversial for patients ongoing bisphosphonates treatment…